Abstract
Since March, 1984, proton beam radiotherapy (PBRT) has been used at the Paul Scherrer Institute (PSI) in a project being conducted jointly with the University Ophthalmological Hospital in Lausanne (Hôpital Ophtalmique Jules Gonin) for the treatment of patients with ocular tumors. Up to now we have treated over 3,000 patients. Among 2,705 cases treated by the end of 1998, there were 2,435 cases of uveal melanoma, 11 of melanoma of the iris, 50 of recurrence of melanoma (some of which had previously been exposed to brachytherapy with Ru-106 or Co-60 plaques), 77 of choroidal hemangioma, 50 of melanoma of the conjunctiva, 32 of intraocular metastases, 34 of age-related macular degeneration, 8 of vascular tumor of the retina, 2 of tumor of the eyelids, and 6 of miscellaneous ocular tumors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Augsburger JJ, Correa ZM, Freire J. et al (1998) Long-term survival in choroidal and ciliary body melanoma after enucleations versus plaque radiation therapy. Ophthalmology 105:1670–1678
Augsburger JJ, Schneider S, Freire J. et al (1999) Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patients treated between 1980 and 1987. Graefes Arch Clin Exp Ophthalmol 237:558–567
Castro JR, Char DH, Petti PL. et al (1997) 15 years’ experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 39:989–996
Char DH, Castro JR, Quivey JM. et al (1989) Uveal melanoma radiation. 125–1 brachytherapy versus helium ion irradiation. Ophthalmology 96:1708–15
Char DH, Quivey JM, Castro JR. et al (1993) Helium ion versus iodine 125 brachytherapy in the management of uveal melanoma. Ophthalmology 100:1547–1554
Char DH, Kroll S, Quivey J, Castro J (1996) Long term visual outcome of radiated uveal melanomas in eyes eligible for randomisation to enucleation versus brachytherapy. Br J Ophthalmol 80: 117–124
Char DH, Kroll SM, Castro J (1997) Long-term follow-up after uveal melanoma charged particle therapy. Trans Am Ophthalmol Soc 95:171–187
Char DH, Kroll SM, Castro J (1998) Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol 125:81–89
Cox D (1972) Regression models and life-tables. J R Stat Soc Ser 34:187–220
Egan KM, Gragoudas ES, Seddon JM. et al (1989) The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology 96:1377–1382
Egger E, Zografos L, Munkel G et al (1997) Results of proton radiotherapy for uveal melanomas. In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds) Radiotherapy of ocular disease. (Frontiers of radiation therapy and oncology, vol 30) Karger, Basel, pp 111–122
Goitein M, Miller T (1983) Planning proton therapy of the eye. Med Phys 10:275–283
Gragoudas ES, Goitein M, Koehler AM. et al (1977) Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol 83:665–673
Gragoudas ES, Goitein M, Verhey L. et al (1980) Proton beam irradiation: an alternative to enucleation for intraocular melanomas. Ophthalmology 87:571–581
Gragoudas ES, Goitein M, Verhey L. et al (1982) Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study. Arch Ophthalmol 100:928–934
Gragoudas ES, Goitein M, Seddon J. et al (1984) Preliminary results of proton beam irradiation of macular and paramacular melanomas. Br J Ophthalmol 68:479–485
Gragoudas ES, Seddon JM, Egan KM. et al (1986) Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology 93:675–680
Gragoudas ES, Seddon JM, Egan K. et al (1987) Long-term results of proton beam irradiated uveal melanomas. Arch Ophthalmol 94:349–353
Gragoudas ES, Seddon JM, Egan KM. et al (1988) Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology 95:992–999
Gragoudas ES, Egan KM, Seddon JM. et al (1992) Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 99:760–766
Kaplan E, Meier P (1958) Nonparametric estimation from incomplete observation. J Am Stat Assoc 53:457–481
Karlsson UL, Augsburger JJ, Shields JA. et al (1989) Recurrence of posterior uveal melanoma after 60CO episcleral plaque therapy. Ophthalmology 96:382–388
Kleineidam M, Guthoff R, Bentzen SM (1993) Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium-106 plaques. Radiother Oncol 28:148–56
Linstadt D, Castro J, Char D. et al (1990) Long-term results of helium ion irradiation of uveal melanoma. Int J Radiat Oncol Biol Phys 19:613–618
Lommatzsch PK, Werschnik C, Schuster E (2000) Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 238:129–137
Manschot WA, van Strik R (1992) Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review. Int Ophthalmol 16:91–99
Munzenrider JE, Gragoudas ES, Seddon JM. et al (1988) Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys 15:553–558
Munzenrider JE, Verhey LJ, Gragoudas ES. et al (1989) Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys 17:493–498
Perret C (1987) The therapy planning program EYE (internal report). Swiss Institute for Nuclear Research, Villigen
Petrovich Z, Luxton G, Langholz B. et al (1992) Episcleral plaque radiotherapy in the treatment of uveal melanomas. Int J Radiat Oncol Biol Phys 24:247–251
Potter R, Janssen K, Prott FJ et al. (1997) Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: evaluation of 175 patients treated with 150 Gy from 1981–1989. In: Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (eds) Radiotherapy of ocular disease. (Frontiers of radiation therapy and oncology, vol 30) Karger, Basel, pp 143–149
Seddon JM, Gragoudas ES, Albert DM. et al (1985) Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol 99:282–290
Seddon JM, Gragoudas ES, Polivogianis L. et al (1986) Visual outcome after proton beam irradiation of uveal melanoma. Ophthalmology 93:666–674
Seddon JM, Gragoudas ES, Egan KM. et al (1987) Uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology 94:354–361
Seddon JM, Gragoudas ES, Egan KM. et al (1990) Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology 97:769–777
Sheen M (1995) EYEPLAN proton therapy planning program (internal report). Clatterbridge Centre for Oncology, Bebington UK
Shields CL, Shields JA, Karlsson U. et al (1989) Reasons for enucleation after plaque radiotherapy for posterior uveal melanoma. Clinical findings. Ophthalmology 96:919–923
Suit HD (1992) Local control and patient survival. Int J Radiat Oncol Biol Phys 23:653–660
Suit HD, Westgate SJ (1986) Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 15:453–458
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Egger, E., Zografos, L., Goitein, G. (2003). Proton Beam Irradiation of Choroidal Melanoma: Technique and Results. In: Sagerman, R.H., Alberti, W.E. (eds) Radiotherapy of Intraocular and Orbital Tumors. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55910-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-55910-5_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63147-4
Online ISBN: 978-3-642-55910-5
eBook Packages: Springer Book Archive